Universitat Autònoma de Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (18)

2024

  1. DRD4 gene polymorphism and impulse control disorder induced by dopamine agonists in Parkinson's disease

    Annals of Clinical and Translational Neurology, Vol. 11, Núm. 8, pp. 2222-2229

2023

  1. Midbrain and pons MRI shape analysis and its clinical and CSF correlates in degenerative parkinsonisms: a pilot study

    European Radiology, Vol. 33, Núm. 7, pp. 4540-4551

2021

  1. Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome

    Nature Communications, Vol. 12, Núm. 1

  2. Human-lineage-specific genomic elements are associated with neurodegenerative disease and APOE transcript usage

    Nature Communications, Vol. 12, Núm. 1

  3. Serum metabolic biomarkers for synucleinopathy conversion in isolated REM sleep behavior disorder

    npj Parkinson's Disease, Vol. 7, Núm. 1

2020

  1. Regulatory sites for splicing in human basal ganglia are enriched for disease-relevant information

    Nature Communications, Vol. 11, Núm. 1

2019

  1. Cerebrospinal fluid cytokines in multiple system atrophy: A cross-sectional Catalan MSA registry study

    Parkinsonism and Related Disorders, Vol. 65, pp. 3-12

  2. Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset

    npj Parkinson's Disease, Vol. 5, Núm. 1

  3. Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability

    npj Parkinson's Disease, Vol. 5, Núm. 1

  4. SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease

    Movement Disorders, Vol. 34, Núm. 9, pp. 1333-1344

  5. The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight

    Movement Disorders, Vol. 34, Núm. 12, pp. 1851-1863

2018

  1. Cerebrospinal fluid levels of coenzyme Q10 are reduced in multiple system atrophy

    Parkinsonism and Related Disorders, Vol. 46, pp. 16-23

  2. α-synuclein (SNCA) but not dynamin 3 (DNM3) influences age at onset of leucine-rich repeat kinase 2 (LRRK2) Parkinson's disease in Spain

    Movement Disorders, Vol. 33, Núm. 4, pp. 637-641

2017

  1. Cross-sectional and longitudinal cognitive correlates of FDDNP PET and CSF amyloid-β and tau in Parkinson's disease

    Journal of Alzheimer's Disease, Vol. 55, Núm. 3, pp. 1261-1272

2016

  1. Knowledge and Attitudes of Nurses in Spain about Inhaled Therapy: Results of a National Survey

    Journal of Aerosol Medicine and Pulmonary Drug Delivery, Vol. 29, Núm. 1, pp. 86-93

2014

  1. Diagnostic validity of the alzheimer's disease functional assessment and change scale in mild cognitive impairment and mild to moderate alzheimer's disease

    Dementia and Geriatric Cognitive Disorders, Vol. 37, Núm. 5-6, pp. 366-375

  2. Spanish multicenter normative studies (NEURONORMA project): Normative data and equivalence of four BNT short-form versions

    Archives of Clinical Neuropsychology, Vol. 29, Núm. 1, pp. 60-74

2010

  1. Gene expression signature in urine for diagnosing and assessing aggressiveness of bladder urothelial carcinoma

    Clinical Cancer Research, Vol. 16, Núm. 9, pp. 2624-2633